Astellas Pharma Inc. Share Price Deutsche Boerse AG
Stocks
YPH
JP3942400007
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Tradegate
12:49:12 20/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 13.05 EUR | +6.10% |
|
+2.42% | +14.11% |
| 17/08 | CLSA Starts Astellas Pharma at Accumulate with 3,000 Yen Price Target | MT |
| 10/08 | AbCellera's menopause drug cuts hot flashes in mid-stage trial, shares surge | RE |
| Market Cap | 4,19000Cr 2.64TCr 2.27TCr 2.12TCr 1.94TCr 3.65TCr 2,52700Cr 3.71TCr 25TCr 9.78TCr 1,26700Cr 9.93TCr 9.71TCr | P/E 2027 * |
11.3x | P/E 2028 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 4,14800Cr 2.62TCr 2.25TCr 2.1TCr 1.92TCr 3.62TCr 2,50200Cr 3.68TCr 25TCr 9.69TCr 1,25500Cr 9.83TCr 9.61TCr | EV / Sales 2027 * |
1.79x | EV / Sales 2028 * | 1.76x |
| Free-Float |
98.88% | Yield 2027 * |
3.44% | Yield 2028 * | 3.55% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +6.10% | ||
| 1 week | +2.42% | ||
| Current month | +9.48% | ||
| 1 month | +10.43% | ||
| 3 months | +4.10% | ||
| 6 months | -5.08% | ||
| Current year | +14.11% |
| 1 week | 12 |  | 12.7 |
| 1 month | 11.3 | | 12.7 |
| Current year | 11 | | 14.19 |
| 1 year | 8.56 | | 14.19 |
| 3 years | 7.53 | | 14.3 |
| 5 years | 7.53 | | 16 |
| 10 years | 7.53 | | 16.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 10/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 01/11/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 10/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 01/06/2019 |
| Director/Board Member | 58 | 01/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.10% | +2.42% | - | - | 2.64TCr | |
| +4.46% | +4.92% | +82.07% | +134.31% | 1,14100Cr | |
| +0.85% | +4.81% | +53.77% | +58.51% | 66TCr | |
| +2.72% | +6.92% | +28.99% | +77.15% | 47TCr | |
| +0.05% | +1.85% | +40.62% | +45.10% | 37TCr | |
| +0.20% | +3.31% | +24.89% | +42.04% | 30TCr | |
| +0.26% | +3.69% | +1.37% | +13.73% | 25TCr | |
| +4.02% | +6.29% | +49.67% | +68.96% | 24TCr | |
| -0.58% | +0.03% | -13.67% | -52.69% | 21TCr | |
| +2.90% | +8.63% | +25.11% | +94.52% | 18TCr | |
| Average | +1.71% | +4.10% | +32.54% | +53.51% | 42.46TCr | |
| Weighted average by Cap. | +1.10% | +4.31% | +46.87% | +74.24% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,31500Cr 1.46TCr 1.25TCr 1.17TCr 1.07TCr 2.02TCr 1,39600Cr 2.05TCr 14TCr 5.41TCr 70TCr 5.49TCr 5.37TCr | 2,13700Cr 1.35TCr 1.16TCr 1.08TCr 990.63Cr 1.86TCr 1,28800Cr 1.89TCr 13TCr 4.99TCr 65TCr 5.06TCr 4.95TCr |
| Net income | 36TCr 224.5Cr 192.58Cr 179.83Cr 164.99Cr 310.25Cr 21TCr 315.36Cr 2.12TCr 830.89Cr 11TCr 842.97Cr 824.63Cr | 33TCr 209.82Cr 179.98Cr 168.06Cr 154.2Cr 289.96Cr 20TCr 294.74Cr 1.98TCr 776.55Cr 10TCr 787.84Cr 770.69Cr |
| Net Debt | -4.19TCr -26Cr -23Cr -21Cr -19Cr -37Cr -2.53TCr -37Cr -249.7Cr -98Cr -1.27TCr -99Cr -97Cr | -44TCr -277.02Cr -237.63Cr -221.89Cr -203.58Cr -382.83Cr -26TCr -389.14Cr -2.62TCr -1.03TCr -13TCr -1.04TCr -1.02TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | €12.70 | +3.25% | 0 |
| 19/26/19 | €12.30 | +0.82% | 0 |
| 18/26/18 | €12.20 | +1.67% | 0 |
| 17/26/17 | €12.00 | -4.76% | 0 |
| 14/26/14 | €12.60 | +1.61% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- YPH Stock
Select your edition
All financial news and data tailored to specific country editions
